000			04178nam a2200421 i 4500
999			_c383665 _d383665
001			383665
003			ES-MaUEC
005			20230102122141.0
006			a|||| o|||| 00| 0
007			cr nn 008mamaa
008			200929s2021 sz a o |||| 0|eng d
020			_a9783030520212
024	7		_a10.1007/978-3-030-52021-2 _2doi
040			_bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC280.U74 _b2021 EB
245	0	0	_aChemotherapy and Immunotherapy in Urologic Oncology : _bA Guide for the Advanced Practice Provider _cedited by Edouard J. Trabulsi, Costas D. Lallas, Anne E. Lizardi-Calvaresi
250			_a1st edition 2021
264		1	_aCham _bSpringer International Publishing _c2021
300			_a1 recurso en línea (XIV, 307 páginas) _b22 ilustraciones, 19 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
505	0		_aIntroduction: Integration of APP into Urologic Oncology Practice -- Overview and Active Surveillance of Prostate Cancer -- Monitoring and Managing Men Following Initial Treatment of Prostate Cancer -- Radical Prostatectomy and Survivorship after Radical Prostatectomy -- Multimodal Treatment Plans in Prostate Cancer -- Radiotherapy for Prostate Cancer -- Androgen Deprivation Treatment -- Second Generation Androgen Targeted Agents -- Chemotherapy and prostate cancer -- Radiopharmaceuticals for Prostate Cancer -- Immunotherapy and Novel Agents on the Horizon for the Treatment of Prostate Cancer -- Bladder Cancer -- Intravesical Therapy for Non Muscle Invasive Urothelial Carcinoma -- Bladder Cancer: Muscle Invasive Disease -- Chemoradiation Bladder Preservation -- Metastatic Bladder Cancer and the Use of Cisplatin Chemotherapy -- Immunotherapy for Metastatic Urothelial Cancer -- Novel and experimental Strategies in the treatment of Metastatic Urothelial Carcinoma -- Upper Tract Urothelial Carcinoma -- Kidney Cancer and Its Treatment -- Targeted Therapies for Treatment of Metastatic Renal Cell Carcinoma -- Immune Therapies for Metastatic Kidney Cancer -- Novel Therapies for Renal Cell Carcinoma -- Testicular Cancer -- Penile Cancer.
520	3		_aThis book is designed to familiarize clinical practitioners in systemic therapy options and medical management of urologic malignancies including prostate cancer, bladder and upper tract urothelial carcinoma, and renal cell carcinoma. Organized by organ system, the text highlights new therapies such as novel forms of androgen deprivation, cytotoxic chemotherapy, immune check point and immunomodulatory agents, and targeted therapies. Written by experts in the field, the book also reviews current chemotherapy and immunotherapy regimens for genitourinary malignancies and discusses indications, outcomes, and toxicities, as well as clinical trial concepts. Each of the book's chapters offers a bulleted box of clinical pearls on the particular role of the APP. Chemotherapy and Immunotherapy in Urologic Oncology: A Guide for the Advanced Practice Provider is a resource for urologists, uro-radiologists, medical clinicians and family practitioners alike, familiarizing its audiences with systemic therapy regimens for urologic malignancies, as well as their expected outcomes and side effects
988			_aSpringer_Medicine_2021
650		7	_2embne _9224160 _aAparato urinario _xCáncer
700	1		_aTrabulsi, Edouard J. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aLallas, Costas D. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
700	1		_aLizardi-Calvaresi, Anne E. _eeditor literario _4edt _4http://id.loc.gov/vocabulary/relators/edt
776	0	8	_iPrinted edition: _z9783030520205
776	0	8	_iPrinted edition: _z9783030520229
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-52021-2 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE
998			_b10/2022 _dz _eb _zSI